Research progress on heterotopic gastric mucosa in the esophagus_West China Medical Journal

Authors：

XIONG Xin ¹ , CHEN Yuan ¹ , LI Shuyi ¹ , XU Zhihong ¹ , ZHANG Xiumei ¹ , TANG Shilin ¹ , GUO Hao ² , HUANG Ping ² ,  HE Suyu ¹

1. Department of Gastroenterology, Suining Central Hospital, Suining, Sichuan 629000, P. R. China;
2. School of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan 637000, P. R. China;

Corresponding?author：

HE Suyu, Email: hesuyu2009@163.com

Keywords：

Heterotopic gastric mucosa in the esophagus; heterotopic gastric mucosa in the upper esophagu; Barrett esophagus; gastroesophageal reflux disease; esophageal adenocarcinoma

DOI：

10.7507/1002-0179.202508044

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Heterotopic gastric mucosa in the esophagus (HGME) refers to the heterotopic distribution of gastric mucosa in the esophagus. Its subtypes include heterotopic gastric mucosa in the upper esophagus, heterotopic gastric mucosa in the middle esophagus and Barrett esophagus. To date, the occurrence, development and clinical characteristics of each subtype are closely related to gastroesophageal reflux disease, but there are few reviews elaborating on their similarities and differences. This report analyzes the commonalities and differences of HGME subtypes from multiple perspectives including pathogenesis, epidemiology, high-risk factors, clinical symptoms, auxiliary examinations, treatment and prognosis, aiming to provide guidance for future research and clinical practice.

Citation： XIONG Xin, CHEN Yuan, LI Shuyi, XU Zhihong, ZHANG Xiumei, TANG Shilin, GUO Hao, HUANG Ping, HE Suyu. Research progress on heterotopic gastric mucosa in the esophagus. West China Medical Journal, 2026, 41(7): 1187-1195. doi: 10.7507/1002-0179.202508044 Copy

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.	Marques de Sá I, Leal C, Silva J, et al. Prevalence of Barrett’s esophagus in a Southern European country: a multicenter study[J]. Eur J Gastroenterol Hepatol, 2021, 33(1S Suppl 1): e939-e943.
23.
24.
25.
26.
27.	Dhaliwal L, Kamboj AK, Williams JL, et al. Prevalence and predictors of Barrett’s esophagus after negative initial endoscopy: analysis from two national databases[J]. Clin Gastroenterol Hepatol, 2024, 22(3): 523-531.e3.
28.	Ebigbo A, Messmann H, Lee SH. Artificial intelligence applications in image-based diagnosis of early esophageal and gastric neoplasms[J]. Gastroenterology, 2025, 169(3): 396-415.e2.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.	Ma S, Tong Z, He Y, et al. Association between hiatal hernia and Barrett’s esophagus: an updated meta-analysis with trial sequential analysis[J]. Therap Adv Gastroenterol, 2024, 17: 17562848231219234.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.	Taylor JB, Rubenstein JH. Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett’s esophagus[J]. Am J Gastroenterol, 2010, 105(8): 1729, 1730-1737, quiz 1738.
60.
61.
62.	熊鑫, 何素玉, 徐菲, 等. 食管上段胃黏膜異位內鏡下合并癥的研究[J]. 中國內鏡雜志, 2021, 27(4): 1-6.
63.	ASGE Standards of Practice Committee, Qumseya B, Sultan S, et al. ASGE guideline on screening and surveillance of Barrett’s esophagus[J]. Gastrointest Endosc, 2019, 90(3): 335-359.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.	Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0?[J]. Neurogastroenterol Motil, 2021, 33(1): e14058.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22. Marques de Sá I, Leal C, Silva J, et al. Prevalence of Barrett’s esophagus in a Southern European country: a multicenter study[J]. Eur J Gastroenterol Hepatol, 2021, 33(1S Suppl 1): e939-e943.
23.
24.
25.
26.
27. Dhaliwal L, Kamboj AK, Williams JL, et al. Prevalence and predictors of Barrett’s esophagus after negative initial endoscopy: analysis from two national databases[J]. Clin Gastroenterol Hepatol, 2024, 22(3): 523-531.e3.
28. Ebigbo A, Messmann H, Lee SH. Artificial intelligence applications in image-based diagnosis of early esophageal and gastric neoplasms[J]. Gastroenterology, 2025, 169(3): 396-415.e2.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38. Ma S, Tong Z, He Y, et al. Association between hiatal hernia and Barrett’s esophagus: an updated meta-analysis with trial sequential analysis[J]. Therap Adv Gastroenterol, 2024, 17: 17562848231219234.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59. Taylor JB, Rubenstein JH. Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett’s esophagus[J]. Am J Gastroenterol, 2010, 105(8): 1729, 1730-1737, quiz 1738.
60.
61.
62. 熊鑫, 何素玉, 徐菲, 等. 食管上段胃黏膜異位內鏡下合并癥的研究[J]. 中國內鏡雜志, 2021, 27(4): 1-6.
63. ASGE Standards of Practice Committee, Qumseya B, Sultan S, et al. ASGE guideline on screening and surveillance of Barrett’s esophagus[J]. Gastrointest Endosc, 2019, 90(3): 335-359.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89. Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0?[J]. Neurogastroenterol Motil, 2021, 33(1): e14058.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.

Previous Article
Application progress of artificial intelligence in exercise management for patients with chronic kidney disease
Next Article
Research progress on osteoporotic acetabular fractures in the elderly

West China Medical Journal

Research progress on heterotopic gastric mucosa in the esophagus

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content